Welcome to EpilepsyU.com a social network dedicated to the epilepsy community

Medical Marijuana

Federal chokehold on marijuana stymies studies on epilepsy, autism

A few years ago, I began to see children in my practice who seemingly responded to marijuana-derived extracts. And as a result, I grew cautiously optimistic that these extracts might be good treatments for the condition. As a devout believer in evidence-based medicine, I still needed experimental data that could distinguish bona fide effectiveness from a deceptive impression of benefit — a placebo effect. But my desire to study marijuana ran headlong into a seemingly immovable obstacle: the U.S. Drug Enforcement Agency (DEA). The agency’s illogical and stubborn stance makes it all but impossible for scientists to study cannabidiol. I persevered and eventually succeeded in launching a study, but no doubt many others give up, robbing us of valuable insight into marijuana’s potential benefits...

Public faith in marijuana outpaces medical research, study finds

Despite limited evidence, Americans have an increasingly positive view of the health benefits of marijuana. Nearly two-thirds believe pot can reduce pain, while close to half say it improves symptoms of anxiety, depression, epilepsy, and multiple sclerosis, according to a new online survey of 9,003 adults. Pennsylvania and New Jersey are among the 30 states, along with the District of Columbia, Guam, and Puerto Rico, that have legalized medical marijuana. But scientists say hard data on the health effects of pot — both positive and negative — are largely missing. Because marijuana is considered an illicit drug by the federal government, research has been scant, though there are efforts underway in Pennsylvania and nationally to remedy that. “I am not surprised at all [by the survey]. At th...

The FDA Says It Will Likely Never Approve Smoking Cannabis

The federal agency joins a community of health experts who think smoking is not a good way to consume weed.   The commissioner of the Food and Drug Administration, Scott Gottlieb, recently suggested that the agency would never approve of smoking cannabis. This opposition to smoking is shared by many health experts, even those who approve of medical cannabis in general. FEATURED PHOTO: WASHINGTON, D.C. – APRIL 05: FDA Commissioner-designate Scott Gottlieb testifies during a Senate Health, Education, Labor and Pensions Committee hearing on April 5, 2017 on Capitol Hill in Washington, D.C. (Photo by Zach Gibson/Getty Images)

Medical Marijuana Won’t Help Most Sick Kids

Medical marijuana appears to hold only limited promise for sick children and teenagers, a new review suggests. It can help kids fighting cancer with chemotherapy-related nausea and vomiting, and it can control seizures somewhat in children with epilepsy, said study author Dr. Shane Shucheng Wong. He is a psychiatrist with Massachusetts General Hospital, in Boston. But there’s not enough evidence to say that medical marijuana can help kids with any other medical conditions, such as neuropathic pain, post-traumatic stress disorder (PTSD) or Tourette’s syndrome, Wong added.

The DEA just gave a big boost to a cannabis-based seizure drug

We are often judged by the company we keep, even unfairly. For decades, that has been the fate of cannabidiol, a chemical compound that has the bad luck to occur naturally in marijuana, the world’s most controversial plant. Because cannabidiol is subject to the same tight legal restrictions on personal and scientific use as is marijuana, its potential medical benefits have been underappreciated — at least up until now.

Cannabis Product Reduces Epileptic Seizures in Lennox-Gastaut Syndrome, Study Shows

A medical cannabis product called RSHO-X dramatically reduced epileptic seizures in a Mexican study of Lennox-Gastaut syndrome, a severe form of childhood epilepsy that responds poorly to treatment. The study covered 39 patients who had daily seizures despite being treated with at least three anti-epileptic drugs. Seventeen percent of the participants had no seizures for at least four months, researchers said. Eighty-four percent had a 50 percent reduction in seizure activity. And more than half, 53 percent, saw their seizure activity drop by 75 percent.

A New Candian Study Shows Dramatic Success With CBD Treatment for Epilepsy

PRESS RELEASE: VANCOUVER, British Columbia, Nov. 24, 2014 (GLOBE NEWSWIRE) — A new study from Orrin Devinsky, MD, of the New York University School of Medicine, suggests that Cannabidiol (CBD) may radically reduce seizures in patients with epilepsy. Dr. Devinsky administered cannabidiol to 23 patients with treatment-resistant epilepsy. Thirty-nine percent of the patients saw their seizure rates drop by more than 50%. Four patients (17%) had no seizures for the last month of treatment. Lexaria (CSE:LXX) (OTCQB:LXRP) has acquired 51% of PoViva Corp, an innovative health company developing Cannabidiol (CBD)-infused products. Lexaria may increase its ownership position to 75% at a later date. “Most CBD’s taste awful,” stated Lexaria CEO and Chairman Chris Bunka in an ex...

VIDEO: Charlotte’s Web for Epilepsy Consortium

The Epilepsy Association of Central Florida, EpilepsyU and The Realm of Caring Florida present “Charlotte’s Web: A Consortium for Understanding Florida’s Compassionate Care Law” at Concorde Career Institute, Orlando Florida. Filmed November 15, 2014 Featuring: Chuck Carmen, Director, Epilepsy Association of Central Florida Dr. Ngoc Minh Le, Epileptologist, Pediatric Neurology, P.A. Paige Figi, Founder, Realm of Caring and mother of Charlotte Figi Holly Moseley, Co-Fouder, Realm of Caring Florida Special thanks goes to Concorde Career Institute for hosting the event. PART 1 of 3 features Mr. Chuck Carmen giving an intro to epilepsy and the speakers and Dr. Le, Epileptologist with a presentation on CBD trials for Dravet and Lennox-Gasteaut Syndromes. PART 2 of 3 features Holley M...

The Case For Whole Plant Legislation – Is CBD Alone Good Enough?

In recent months, one strain of cannabis has been talked about, and legalized more than any other; Charlotte’s Web, a strain of Marijuana bred by Realm of Caring, a group of growers and dispensary owners in Colorado, for its high CBD content. CBD is the least controversial Cannabinoid found in the plant, and there are hundreds, if not thousands of stories to support that it can help reduce seizures. An effect of this new media, legislative and social media blitz of coverage on CBD is that people now seem to think that Charlotte’s Web is the only viable source of CBD, and that CBD alone is effective in seizure control, this is leading parents from across the nation to move to Colorado for access to Charlotte’s web specifically, because they believe that is the only legal w...

U.S. Rep. Scott Perry announces bill for national legalization of medical marijuana oil for seizures

In a move that could trump state legislative actions in Pennsylvania and across the nation, U.S. Rep. Scott Perry is on Monday introducing a bill to nationally legalize a marijuana-based oil that has been shown to reduce seizures in children with debilitating epilepsy. The conservative York County Republican made the announcement Monday morning at a press conference where he was joined by the president of the national Epilepsy Foundation and advocates that included the mother of Colorado girl Charlotte Figi, whose successful treatment with cannabidiol oil has inspired a national movement. Joel Stanley, one of the creators of the “Charlotte’s Web” strain of marijuana used to treat Figi, was also present for the introduction announcement of Perry’s bill, the “Ch...

In Colorado, Thousands on Wait List for Marijuana to Treat Childhood Epilepsy

LITTLETON, COLORADO — The United States government classifies marijuana as an illegal drug, but nearly half the states have legalized the substance to some degree. Proponents say some strains of marijuana might have exceptional health benefits for treating pain or inflammation in chronic conditions such as cancer, multiple sclerosis and epilepsy. A strain of medical marijuana developed in Colorado is reputed to reduce seizures in childhood epilepsy and it’s made a big difference in the life of Maggie Selmeski.

Experimental Cannabis Derived Medicine Shows Promising Results

(Reuters) – An experimental cannabis drug has produced promising results in a small study of children with hard-to-treat epilepsy, sending shares in its British maker GW Pharmaceuticals to an all-time high. The company, which grows cannabis under license at a secret location in Britain, is developing a range of so-called cannabinoid medicines. It already sells Sativex for spasticity caused by multiple sclerosis across Europe. The latest findings for its new product Epidiolex follow an assessment of 27 children and young adults with treatment-resistant epilepsy who were given the drug in two U.S. hospitals under an expanded access program. Epidiolex is given as a strawberry-lime flavored syrup twice a day. The medicine contains the cannabinoid CBD but none of the psychoactive ingredie...